Light Chain Deposition Disease: An Unusual Cause of Portal Hypertension
- PMID: 34448237
- DOI: 10.1002/hep.32118
Light Chain Deposition Disease: An Unusual Cause of Portal Hypertension
Abstract
Light chain deposition disease (LCDD) is a rare entity that is generally discovered in the setting of solid organ dysfunction. The monoclonal gammopathy leads to abnormal deposition of light chains in tissues, most often manifested by way of renal dysfunction. Other organ systems may also be affected, the liver being the second-most common after the kidneys. Liver involvement rarely leads to clinically significant disease, with few case reports in the literature. We present the case of a patient referred to a hepatology clinic for the evaluation of new-onset ascites resulting from portal hypertension secondary to LCDD involving the liver.
© 2021 by the American Association for the Study of Liver Diseases.
References
-
- Randall RE, Williamson WC, Jr., Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med 1976;60:293-299.
-
- Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999;13:1235-1248.
-
- Pozzi C, Locatelli F. Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol 2002;22:319-330.
-
- Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 1992;6:323-346.
-
- McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW. Plasma Cell Neoplasms in WHO Classification of Tumours of Haematolpoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources